Loading...
XNYS
FTV
Market cap18bUSD
Jul 09, Last price  
61.15USD
1D
-0.20%
1Q
4.78%
Jan 2017
80.81%
IPO
95.74%
Name

Fortive Corp

Chart & Performance

D1W1MN
XNYS:FTV chart
P/E
32.19
P/S
3.63
EPS
1.90
Div Yield, %
0.39%
Shrs. gr., 5y
-2.31%
Rev. gr., 5y
2.10%
Revenues
5.14b
-17.48%
5,785,300,0005,961,900,0006,337,200,0006,178,800,0006,224,300,0005,756,100,0006,452,700,0004,563,900,0004,634,400,0005,254,700,0005,825,700,0006,065,300,0006,231,800,0005,142,599,999
Net income
579m
-30.46%
763,700,000830,900,000883,400,000863,800,000872,300,0001,044,500,0002,913,800,000738,900,0001,613,300,000608,400,000755,200,000865,800,000832,900,000579,200,000
CFO
1.08b
-29.05%
944,000,0001,030,200,000946,700,0001,009,000,0001,136,900,0001,176,400,0001,344,400,0001,271,400,0001,436,700,000961,100,0001,303,200,0001,353,600,0001,526,800,0001,083,200,000
Dividend
Nov 28, 20250.06 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
IPO date
Jun 13, 2016
Employees
25,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT